Enveric Biosciences (ENVB) Gross Profit (2014 - 2020)
Enveric Biosciences (ENVB) posted Gross Profit of $1.9 million for Q3 2020, up 3.82% sequentially from $1.8 million in Q2 2020, and down 0.63% YoY from $1.9 million in Q4 2019.
Enveric Biosciences (ENVB) Gross Profit (2014 - 2020) Analysis & Trends
Enveric Biosciences has reported Gross Profit for 7 years, with the latest figure at $1.9 million in Q3 2020.
- Quarterly Gross Profit fell 0.63% year-over-year to $1.9 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $7.3 million (down 12.14% YoY) and the FY2019 annual result came in at $8.2 million, down 9.27% from the prior year.
- Gross Profit improved to $1.9 million in Q3 2020 per ENVB's latest filing, from $1.8 million in the prior quarter.
- Over five years, Gross Profit peaked at $3.3 million in Q1 2017 and troughed at $1.3 million in Q1 2016.
- A 5-year average of $2.1 million and a median of $2.0 million in 2017 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2016 and 2017: Gross Profit sank 37.9% in 2016, then surged 162.92% in 2017.
- Over 5 years, Gross Profit stood at $2.1 million in 2016, then retreated by 1.3% to $2.0 million in 2017, then declined by 6.58% to $1.9 million in 2018, then decreased by 9.27% to $1.7 million in 2019, then grew by 9.16% to $1.9 million in 2020.
- According to Business Quant data, Gross Profit over the past three periods registered $1.9 million, $1.8 million, and $1.9 million for Q3 2020, Q2 2020, and Q1 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Enveric Biosciences | 5.66 Mn | -2.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 1.89 Mn |
| Sep 30, 2020 | 1.89 Mn |
| Jun 30, 2020 | 1.82 Mn |
| Jun 30, 2020 | 1.82 Mn |
| Mar 31, 2020 | 1.88 Mn |
| Mar 31, 2020 | 1.88 Mn |
| Dec 31, 2019 | 1.73 Mn |
| Dec 31, 2019 | 1.73 Mn |
| Sep 30, 2019 | 1.90 Mn |
| Sep 30, 2019 | 1.90 Mn |
| Jun 30, 2019 | 2.38 Mn |
| Jun 30, 2019 | 2.38 Mn |
| Mar 31, 2019 | 2.14 Mn |
| Mar 31, 2019 | 2.14 Mn |
| Dec 31, 2018 | 1.91 Mn |
| Dec 31, 2018 | 1.91 Mn |
| Sep 30, 2018 | 2.35 Mn |
| Sep 30, 2018 | 2.35 Mn |
| Jun 30, 2018 | 2.39 Mn |
| Jun 30, 2018 | 2.39 Mn |